Category: Pharmaceuticals
Global Pharmaceuticals
-
Global Urology Surgical Instruments Databank Market Report
... 2021 to 2029. Endoscopes segment is expected to be the highest contributor to this market, with $4,160.0 Million in 2020, and is anticipated to reach $6,777.1 Million by 2029, registering a CAGR of 5.61%. Envision ... Read More
-
Global Scleroderma Therapeutics Databank Market Report
... 2031. Immunosuppressors segment is expected to be the highest contributor to this market, with $1,235.9 Million in 2022, and is anticipated to reach $1,832.6 Million by 2031, registering a CAGR of 4.52%. Prostacyclin Analogues segment ... Read More
-
Global Cancer Diagnostics Databank Market Report
... 2031. Consumables segment is expected to be the highest contributor to this market, with $167,321.8 Million in 2022, and is anticipated to reach $261,623.1 Million by 2031, registering a CAGR of 5.13%. Instruments segment is ... Read More
-
Global Metabolic Testing Databank Market Report
... 2029. Body Composition Analyzers segment is expected to be the highest contributor to this market, with $256.7 Million in 2020, and is anticipated to reach $394.6 Million by 2029, registering a CAGR of 4.94%. Body ... Read More
-
Global Medication Management System Databank Market Report
... 2023 to 2031. Clinical Decision Support System Solutions segment is expected to be the highest contributor to this market, with $547.7 Million in 2022, and is anticipated to reach $1,113.3 Million by 2031, registering a ... Read More
-
Global Skin Boosters Databank Market Report
... 2031. Mesotherapy segment is expected to be the highest contributor to this market, with $543.3 Million in 2022, and is anticipated to reach $1,044.1 Million by 2031, registering a CAGR of 7.58%. Micro-needle segment is ... Read More
-
Global Pharmaceutical Filtration Databank Market Report
... 2031. Membrane filters segment is expected to be the highest contributor to this market, with $5,579.4 Million in 2022, and is anticipated to reach $12,195.3 Million by 2031, registering a CAGR of 9.13%. Cartridges & ... Read More
-
Global Acute Coronary Syndrome Therapeutic Databank Market Report
... 4.44% from 2023 to 2031. Non-St-Elevation Myocardial Infarction segment is expected to be the highest contributor to this market, with $3,528.2 Million in 2022, and is anticipated to reach $4,904.8 Million by 2031, registering a ... Read More
-
Global Periodontal Scalers And Curettes Databank Market Report
... 7.50% from 2021 to 2029. Curved segment is expected to be the highest contributor to this market, with $9,385.5 Million in 2020, and is anticipated to reach $17,484.7 Million by 2029, registering a CAGR of ... Read More
-
Global Viral Conjunctivitis Pipeline Drugs Databank Market Report
... 3.20% from 2023 to 2031. DST-100 segment is expected to be the highest contributor to this market, with $2,017.3 Million in 2022, and is anticipated to reach $2,548.2 Million by 2031, registering a CAGR of ... Read More
-
Global Hepatitis Diagnostic Test Databank Market Report
... 2023 to 2031. Blood tests segment is expected to be the highest contributor to this market, with $2,457.2 Million in 2022, and is anticipated to reach $3,721.6 Million by 2031, registering a CAGR of 4.76%. ... Read More
-
Global Intranasal Drug & Vaccine Delivery Databank Market Report
... CAGR of 5.50% from 2023 to 2031. Liquid Delivery Device segment is expected to be the highest contributor to this market, with $18,785.8 Million in 2022, and is anticipated to reach $28,078.9 Million by 2031, ... Read More
-
Global Local Anesthesia Drugs Databank Market Report
... 2023 to 2031. Lidocaine segment is expected to be the highest contributor to this market, with $1,877.2 Million in 2022, and is anticipated to reach $2,186.7 Million by 2031, registering a CAGR of 1.75%. Bupivacaine ... Read More
-
Global Brain Cancer Diagnostics Databank Market Report
... 2023 to 2031. Imaging Test segment is expected to be the highest contributor to this market, with $694.7 Million in 2022, and is anticipated to reach $1,223.4 Million by 2031, registering a CAGR of 6.54%. ... Read More
-
Global Ophthalmology Drugs Databank Market Report
... 2031. Anti-VEGF Agents segment is expected to be the highest contributor to this market, with $14,005.3 Million in 2022, and is anticipated to reach $23,509.4 Million by 2031, registering a CAGR of 5.97%. Antiallergy segment ... Read More
-
Global Breast Pump Databank Market Report
... 2031. Open System segment is expected to be the highest contributor to this market, with $1,771.7 Million in 2022, and is anticipated to reach $3,121.8 Million by 2031, registering a CAGR of 6.54%. Closed System ... Read More
-
Global Ophthalmology PACS Databank Market Report
... from 2021 to 2029. Integrated segment is expected to be the highest contributor to this market, with $112.7 Million in 2020, and is anticipated to reach $222.3 Million by 2029, registering a CAGR of 7.88%. Read More
-
Global Olibanum Gum Databank Market Report
... 2031. Technical Grade segment is expected to be the highest contributor to this market, with $557.7 Million in 2022, and is anticipated to reach $686.1 Million by 2031, registering a CAGR of 2.36%. Pharma Grade ... Read More
-
Global Vitamin E Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... properties and is often found in wheat germ oil, egg yolk, and leafy vegetables, it is an important vitamin for humans and animals. As an antioxidant and important vitamins, VE can be added as an ... Read More
-
Global Transdermal Drug Delivery System Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such ... Read More
-
Global Transdermal Drug Delivery System Market Size, Manufacturers, Opportunities and Forecast to 2030
... medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. An advantage of a transdermal drug delivery route over other types of medication delivery such as ... Read More
-
Global Legal Marijuana Market Analysis and Forecast 2024-2030
... basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these ... Read More
-
Global Bromelain Databank Market Report
... segment is expected to be the highest contributor to this market, with $13,380.4 Million in 2022, and is anticipated to reach $24,112.7 Million by 2031, registering a CAGR of 6.81%. Healthcare and Dietary Supplements segments ... Read More
-
Global Drugs for Malaria Market Size, Manufacturers, Opportunities and Forecast to 2030
... in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria ... Read More
-
Global Hematologic Malignancies Databank Market Report
... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More
Research Assistance
